亞太區股市全面隨外圍偏軟 惟新西蘭逆市屢創紀錄高
美股昨晚全面回軟結束四連漲,雖然美國9月NFIB小型企業信心及10月IBD經濟樂觀指數分別創七個月及八個月高遠勝預期,但新冠肺炎疫苗研發有不利消息,加上美國眾議院議長佩洛西拒絕接納白宮提出1.8萬億美元支援經濟方案新建議,影響投資氣氛,逾三分二藍籌回吐,尤其是Walgreens、因有接種疫苗後患上不明疾病暫停測試旗下新冠肺炎疫苗的強生、蘋果、波音及Travelers跌逾2%-3%,摩通上季意外多賺4%,但淨利息收入跌近10%,股價跌1.6%,花旗上季少賺34%仍勝預期,但股價跌4.8%,其他主要銀行股也跌逾1.5%-3.5%,但重組傳媒及娛樂業務的迪士尼逆升逾3%,沃爾瑪也升1.4%,道指由曾吐233點,收窄至僅吐157點或近0.6%收28,679,標普也吐0.6%,微軟逆市續升近0.7%,支持納指僅反覆吐0.1%。此外,歐洲主要股市跌0.5%-1.1%。
美股期貨全面反覆回穩,納指期貨回升0.3%報12,127,道指及標普期貨分別報28,590及3,508,反覆微升5點及3點。不過,亞太區股市普遍受壓。美元兌日圓於亞洲再度回落至105.3,日經繼昨天反覆微彈0.2%後,今早跌0.3%報23,543。
台灣加權指數及韓股繼昨天微吐結束八連漲後,現造12,914及2,386,續吐近0.3%及0.7%。澳洲200繼昨天受惠銀行股推動續升1%後,今早微吐0.1%報6,190。
新加坡第三季GDP初值季調後環比恢復增長7.9%(前值萎縮擴至13.2%)。但星股扭兩連升,報2,560,跌0.3%。馬股未能延續昨天反彈勢,報1,521,跌0.2%。
港股繼昨天颱風休市後,今早復市延續之前急彈逾2%強勢,高開159點或0.6%報24,808欠承接,在三年來首次不在中國美元債承銷商之列匯控(00005.HK)股價挫逾3.5%主導,掉頭低見24,569,現造24,595,倒跌54點或0.2%。
內地9月以美元計價出口額按年升幅加快至9.9%略遜預期,但進口額按年急彈13.2%遠勝預期,期內貿易順差環比意外收窄至370億美元,遠低市場預期環比順差擴至600億美元。深成及滬指繼昨天反覆續升近0.7%及靠穩後,今早低開0.2%及0.1%分別報3,353及13,781,現造3,346及13,741,回吐0.4%。
不過,新西蘭連續第五天創紀錄高,今早高低見12,505/12,431,現造12,493,續升0.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.